Results 91 to 100 of about 635,087 (280)

Epidemic size, duration and vaccine stockpiling following a large-scale attack with smallpox

Global Biosecurity, 2019
On August 16th, 2018, we held Exercise Mataika to test preparedness for a worst-case scenario of a smallpox attack which begins in the Pacific and is followed by a larger scale attack in a highly populous Asian country.
C. R. MacIntyre, Valentina Costantino, B. Mohanty, D. Nand, M. Kunasekaran, D. Heslop   +5 more
semanticscholar   +1 more source

Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re‐emergence

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Introduction Re‐emerging infectious diseases pose significant public health challenges in Africa and demand robust and coordinated responses. The Mpox virus (MPXV) has increasingly caused outbreaks with global implications, highlighting the vulnerabilities of the continent's health systems.
Kesaobaka Batisani, Tolulope Joseph Ogunniyi   +1 more
wiley   +1 more source

Smallpox and Bioterrorism: Why the Plan to Protect the Nation Is Stalled and What to Do [PDF]

, 2003
The Iraq war is over, no weapons of mass destruction (WMD) have yet been found, and the president's smallpox plan, though sound, is running out of steam. Instead of being well on the way to protecting the nation's civilian population by vaccinating up to
Kenneth D. Bloem, William J. Bicknell
core  

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

Open Forum Infectious Diseases, 2015
Background First- and second-generation smallpox vaccines are contraindicated in individuals infected with human immunodeficiency virus (HIV). A new smallpox vaccine is needed to protect this population in the context of biodefense preparedness.
E. Overton, J. Stapleton, I. Frank, Shawn Hassler, P. Goepfert, David E. Barker, E. Wagner, A. von Krempelhuber, G. Virgin, J. Weigl, T. Meyer, Jutta Müller, Nicole Bädeker, Robert Gruenert, P. Young, Siegfried Rösch, J. Maclennan, Nathaly Arndtz-Wiedemann, P. Chaplin   +18 more
semanticscholar   +1 more source

Systematic Review of Postvaccination Ocular Adverse Events: A Comprehensive Analysis of Published Reports

Journal of Medical Virology, Volume 97, Issue 12, December 2025.
ABSTRACT Ocular adverse events following COVID‐19 vaccination are well described; however, systematic analyses of non‐COVID antiviral vaccines remain limited. This review aimed to evaluate ocular complications associated with non‐COVID antiviral immunizations, including influenza, varicella‐zoster (VZV), human papillomavirus (HPV), and hepatitis B (HBV)
Yaru Zou, Koju Kamoi, Yuan Zong, Jing Zhang, Mingming Yang, Kyoko Ohno‐Matsui   +5 more
wiley   +1 more source

Strategies for the Modification of Vaccinia Virus towards a Better Vaccine Vector

Zoonoses
Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been extensively exploited as a preventive vaccine.
Hao Sun, Xinwen Chen, Yun Wang
doaj   +1 more source

Impaired Cellular Immunity and Cross‐Reactive Humoral Responses to Mpox Virus in HIV‐Infected Individuals Vaccinated with Vaccinia Virus Tiantan Strain

MedComm, Volume 6, Issue 12, December 2025.
This study examines MPXV immunity in PLWH, focusing on smallpox vaccine‐induced responses. PLWH with CD4⁺ T‐cell counts <500 cells/mm3 showed reduced VTT‐IgG, MPXV‐IgG, and NAbs, while CD4⁺ T‐cell responses were impaired at counts <350 cells/mm3. CD8⁺ T‐cell responses remained stable.
Qiao Zhang, Rui Song, Yu Huang, Meiyu Fang, Xiaoyou Chen, Danyang Li, Yanan Li, Xueqi Chi, Fengwen Xu, Jingchuan Zhong, Lan Chen, Zhixia Gu, Hongxin Zhao, Yuanyuan Zhang, Ning Han, Elie Antoun, Yanchun Peng, Tao Dong, Li Guo, Fei Guo, Lili Ren, Jianwei Wang, Ronghua Jin   +22 more
wiley   +1 more source

Scientists' Warning to Humanity: The Need to Begin Teaching Critical and Systems Thinking Early in Life

Microbial Biotechnology, Volume 18, Issue 12, December 2025.
ABSTRACT We live in a time of global crises: a deteriorating environment that is struggling to provide all the resources and services we demand of it, changing climate and its consequences for the biosphere, its habitats, inhabitants and biodiversity, conflicts‐divisive ideologies‐competition for resources, increasing societal inequalities and human ...
Kenneth Timmis, Fernando Baquero, Rup Lal, Lara Raquel Pinto Amorim, Pablo Ivan Nikel, Jasvinder Kaur, Utkarsh Sood, Pushp Lata, Shalini Singh, Jake M. Robinson, Max Chavarria, Willy Verstraete, Patricia Bernal, Horia Banciu, Karen Steward, Joachim Frey, Antoine Danchin, Anna Karnkowska, Oleg Kotsyurbenko, Cristina Silva Pereira, Eric S. Boyd, John E. Hallsworth, Olga Nunes, Zulema Udaondo, Wei Huang, Yun Wang, Zeynep Ceren Karahan, Pilar Junier, Eliora Ron, Juan Luis Ramos   +29 more
wiley   +1 more source

ACAM2000&trade;: The new smallpox vaccine for United States Strategic National Stockpile

Drug Design, Development and Therapy, 2010
Aysegul Nalca, Elizabeth E ZumbrunCenter for Aerobiological Sciences, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD, USAAbstract: Smallpox was eradicated more than 30 years ago, but heightened concerns over ...
Aysegul Nalca, Elizabeth E Zumbrun
doaj  

Le vaccin et ses simulacres : instaurer un être pour gérer une population, 1800-1865

Tracés, 2011
The story of the smallpox vaccine is of particular interest for analysing the role of knowledge in the exercise of power after the Revolution. Rather than establishing compulsory vaccination, the French Government decided to intervene in the medical ...
Jean-Baptiste Fressoz
doaj   +1 more source